Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Targeting tumors with nanobodies for cancer imaging and therapy.

Oliveira S, Heukers R, Sornkom J, Kok RJ, van Bergen En Henegouwen PM.

J Control Release. 2013 Dec 28;172(3):607-17. doi: 10.1016/j.jconrel.2013.08.298. Epub 2013 Sep 11. Review.

PMID:
24035975
2.

Nanobody-based cancer therapy of solid tumors.

Kijanka M, Dorresteijn B, Oliveira S, van Bergen en Henegouwen PM.

Nanomedicine (Lond). 2015 Jan;10(1):161-74. doi: 10.2217/nnm.14.178. Review.

3.

Antibodies and peptides in cancer therapy.

Khandare JJ, Minko T.

Crit Rev Ther Drug Carrier Syst. 2006;23(5):401-35. Review.

PMID:
17425513
4.

Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.

Majidi J, Barar J, Baradaran B, Abdolalizadeh J, Omidi Y.

Hum Antibodies. 2009;18(3):81-100. doi: 10.3233/HAB-2009-0204. Review.

PMID:
19729803
5.

Nanobodies as novel agents for cancer therapy.

Revets H, De Baetselier P, Muyldermans S.

Expert Opin Biol Ther. 2005 Jan;5(1):111-24. Review.

PMID:
15709914
6.
7.

Nanoparticle-based tumor theranostics with molecular imaging.

Wang L, Wang Y, Li Z.

Curr Pharm Biotechnol. 2013;14(7):683-92. Review.

PMID:
24372235
8.

Targeting epidermal growth factor receptor in tumors: from conventional monoclonal antibodies via heavy chain-only antibodies to nanobodies.

Altintas I, Kok RJ, Schiffelers RM.

Eur J Pharm Sci. 2012 Mar 12;45(4):399-407. doi: 10.1016/j.ejps.2011.10.015. Epub 2011 Oct 28. Review.

PMID:
22064454
9.

Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.

Bodey B, Siegel SE, Kaiser HE.

Anticancer Res. 1996 Mar-Apr;16(2):661-74. Review.

PMID:
8687112
10.

Nanobodies as novel agents for disease diagnosis and therapy.

Siontorou CG.

Int J Nanomedicine. 2013;8:4215-27. doi: 10.2147/IJN.S39428. Epub 2013 Jan 11. Review.

11.

[Molecular target therapy: a milestone on the road for curing cancer].

Zeng YX, Zhang XS, Liu Q.

Ai Zheng. 2008 Aug;27(8):785-7. Chinese.

PMID:
18710609
12.

Development of NGR-based anti-cancer agents for targeted therapeutics and imaging.

Wang RE, Niu Y, Wu H, Hu Y, Cai J.

Anticancer Agents Med Chem. 2012 Jan;12(1):76-86. Review.

PMID:
22023047
13.

Nanobodies targeting the hepatocyte growth factor: potential new drugs for molecular cancer therapy.

Vosjan MJ, Vercammen J, Kolkman JA, Stigter-van Walsum M, Revets H, van Dongen GA.

Mol Cancer Ther. 2012 Apr;11(4):1017-25. doi: 10.1158/1535-7163.MCT-11-0891. Epub 2012 Feb 7.

14.

[Molecular imaging in cancer therapy].

Weber WA.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Aug;53(8):810-7. doi: 10.1007/s00103-010-1092-1. Review. German.

PMID:
20700780
15.

Tumor-directed targeting of liposomes.

Park YS.

Biosci Rep. 2002 Apr;22(2):267-81. Review.

PMID:
12428904
17.

In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.

Vaneycken I, Govaert J, Vincke C, Caveliers V, Lahoutte T, De Baetselier P, Raes G, Bossuyt A, Muyldermans S, Devoogdt N.

J Nucl Med. 2010 Jul;51(7):1099-106. doi: 10.2967/jnumed.109.069823. Epub 2010 Jun 16.

18.

Nanobody; an old concept and new vehicle for immunotargeting.

Rahbarizadeh F, Ahmadvand D, Sharifzadeh Z.

Immunol Invest. 2011;40(3):299-338. doi: 10.3109/08820139.2010.542228. Epub 2011 Jan 11. Review.

PMID:
21244216
19.

Oligo-clonal nanobodies as an innovative targeting agent for cancer therapy: New biology and novel targeting systems.

Nikkhoi SK, Rahbarizadeh F, Ahmadvand D.

Protein Expr Purif. 2017 Jan;129:115-121. doi: 10.1016/j.pep.2016.09.012. Epub 2016 Sep 28.

PMID:
27693491
20.

How can we improve antibody-based cancer therapy?

Yan L, Ehrlich PJ, Gibson R, Pickett C, Beckman RA.

MAbs. 2009 Jan-Feb;1(1):67-70.

Supplemental Content

Support Center